Usnic acid inhibits biofilm formation and virulent morphological traits of Candida albicans

Microbiological Research

Volumn 179, Issue , 2015, Pages 20-28

  Nithyanand, Paramasivam ^a   Beema Shafreen, Raja Mohmed ^b   Muthamil, Subramanian ^b   Karutha Pandian, Shunmugiah ^b  

^a SASTRA UNIVERSITY   (India)

^b ALAGAPPA UNIVERSITY   (India)

Author keywords

Biofilms; Candida morphogenesis; Lichen secondary metabolite

Indexed keywords

BIOMOLECULES; CANDIDA; METABOLITES; YEAST;

BIOFILM FORMATION; BIOFILM INHIBITIONS; EXOPOLYSACCHARIDES; INHIBITORY CONCENTRATION; MICROSCOPIC IMAGE; MORPHOLOGICAL TRAITS; SECONDARY METABOLITES; VIRULENCE FACTORS;

BIOFILMS;

BIOFILM; CELLS AND CELL COMPONENTS; CONCENTRATION (COMPOSITION); DIBENZOFURAN; FORMATION MECHANISM; FUNGUS; INHIBITION; LICHEN; MORPHOGENESIS; MORPHOLOGY; POLYSACCHARIDE; SECONDARY METABOLITE; VIABILITY; VIRULENCE;

CANDIDA; CANDIDA ALBICANS;

ANTIFUNGAL AGENT; BENZOFURAN DERIVATIVE; USNIC ACID;

BIOFILM; CANDIDA ALBICANS; CONFOCAL MICROSCOPY; DRUG EFFECTS; FUNGUS HYPHAE; INFRARED SPECTROSCOPY; LICHEN (ORGANISM); METABOLISM; PATHOGENICITY; PHYSIOLOGY; VIRULENCE;

ANTIFUNGAL AGENTS; BENZOFURANS; BIOFILMS; CANDIDA ALBICANS; HYPHAE; LICHENS; MICROSCOPY, CONFOCAL; SPECTROSCOPY, FOURIER TRANSFORM INFRARED; VIRULENCE;

EID: 84942155483     PISSN: 09445013     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.micres.2015.06.009     Document Type: Article

References (39)

1. Al-Fattani M.A., Douglas L.J. Biofilm matrix of Candida albicans and Candida tropicalis: chemical composition and role in drug resistance. J Med Microbiol 2006, 55:999-1008.
2. Ansari M.J., Al-Ghamdi A., Usmani S., Al-Waili N.S., Sharma D., Nuru A., et al. Effect of jujube honey on Candida albicans growth and biofilm formation. Arch Med Res 2013, 44:352-360.
3. Bachmann S.P., VandeWalle K., Ramage G., Patterson T.F., Wickes B.L., Graybill J.R., et al. In vitro activity of caspofungin against Candida albicans biofilms. Antimicrob Agents Chemother 2002, 46:3591-3596.
4. Cannon R.D., Lamping E., Holmes A.R., Niimi K., Baret P.V., Keniya M.V., et al. Efflux-mediated antifungal drug resistance. Clin Microbiol Rev 2009, 22:291-321.
5. Christensen G.D., Simpson W.A., Bisno A.L., Beachey E.H. Adherence of slime-producing strains of Staphylococcus epidermidis to smooth surfaces. Infect Immun 1982, 37:318-326.
6. Fazly A., Jain C., Dehner A.C., Issi L., Lilly E.A., Ali A., et al. Chemical screening identifies filastatin, a small molecule inhibitor of Candida albicans adhesion, morphogenesis, and pathogenesis. Proc Natl Acad Sci U S A 2013, 110:13594-13599.
7. Francolini I., Norris P., Piozzi A., Donelli G., Stoodley P. Usnic acid, a natural antimicrobial agent able to inhibit bacterial biofilm formation on polymer surfaces. Antimicrob Agents Chemother 2004, 48:4360-4365.
8. Gauwerky K., Borelli C., Korting H.C. Targeting virulence: a new paradigm for antifungals. Drug Discov Today 2009, 14:214222.
9. Goldie S.J., Kiernan-Tridle L., Torres C., Gorban-Brennan N., Dunne D., Kliger A.S., et al. Fungal peritonitis in a large chronic peritoneal dialysis population: a report of 55 episodes. Am J Kidney Dis 1996, 28:86-91.
10. Gonçalves L.M., Del Bel Cury A.A., de Vasconcellos A.A., Cury J.A., da Silva W.J. Confocal analysis of the exopolysaccharide matrix of Candida albicans biofilms. J Invest Clin Dent 2014, 10.1111/jicd.12093.
11. Jarvis W.R. Epidemiology of nosocomial fungal infections, with emphasis on Candida species. Clin Infect Dis 1995, 20:1526-1530.
12. Kavanaugh N.L., Zhang A.Q., Nobile C.J., Johnson A.D., Ribbeck K. Mucins suppress virulence traits of Candida albicans. MBio 2014, 5(6):e01911.
13. Kojic E.M., Darouiche R.O. Candida infections of medical devices. Clin Microbiol Rev 2004, 17:255-267.
14. Lal P., Sharma D., Pruthi P., Pruthi V. Exopolysaccharide analysis of biofilm-forming Candida albicans. J Appl Microbiol 2010, 109:128-136.
15. Liu H., Köhler J., Fink G.R. Suppression of hyphal formation in Candida albicans by mutation of a STE12 homolog. Science 1994, 266:1723-1726.
16. Lupetti A., Danesi R., Campa M., Del Tacca M., Kelly S. Molecular basis of resistance to azole antifungals. Trends Mol Med 2002, 8:76-81.
17. Michel C., Courdavault L., al Khayat R., Viron B., Roux P., Mignon F. Fungal peritonitis in patients on peritoneal dialysis. Am J Nephrol 1994, 14:113-120.
18. Nett J., Andes D. Candida albicans biofilm development, modelling a host-pathogen interaction. Curr Opin Microbiol 2006, 9:340-345.
19. Nett J.E., Cain M.T., Crawford K., Andes D.R. Optimizing a Candida biofilm microtiter plate model for measurement of antifungal susceptibility by tetrazolium salt assay. J Clin Microbiol 2011, 49:1426-1433.
20. Nett J.E., Guite K.M., Ringeisen A., Holoyda K.A., Andes D.R. Reduced biocide susceptibility in Candida albicans biofilms. Antimicrob Agents Chemother 2008, 52:3411-3413.
21. Nieminen M.T., Novak-Frazer L., Rautemaa W., Rajendran R., Sorsa T., Ramage G., et al. A novel antifungal is active against Candida albicans biofilms and inhibits mutagenic acetaldehyde production in vitro. PLOS ONE 2014, 9(7):e101859.
22. Nithya C., Devi M.G., Karutha Pandian S. A novel compound from the marine bacterium Bacillus pumilus S6-15 inhibits biofilm formation in gram-positive and gram-negative species. Biofouling 2011, 27:519-528.
23. Nithyanand P., Beema Shafreen R.M., Muthamil S., Karutha Pandian S. Usnic acid, a lichen secondary metabolite inhibits Group A Streptococcus biofilms. Antonie Van Leeuwenhoek 2015, 107:262-273.
24. Nithyanand P., Thenmozhi R., Rathna J., Pandian S.K. Inhibition of Streptococcus pyogenes biofilm formation by coral-associated actinomycetes. Curr Microbiol 2010, 60:454-460.
25. Pires R.H., Lucarini R., Mendes-Giannini M.J. Effect of usnic acid on Candida orthopsilosis and C. parapsilosis. Antimicrob Agents Chemother 2012, 56:595-597.
26. Pompilio A., Pomponio S., Di Vincenzo V., Crocetta V., Nicoletti M., Piovano M., et al. Antimicrobial and antibiofilm activity of secondary metabolites of lichens against methicillin-resistant Staphylococcus aureus strains from cystic fibrosis patients. Future Microbiol 2013, 8:281-292.
27. Rajendran R., Sherry L., Lappin D.F., Nile C.J., Smith K., Williams C., et al. Extracellular DNA release confers heterogeneity in Candida albicans biofilm formation. BMC Microbiol 2014, 14:303.
28. Ramage G., Saville S.P., Thomas D.P., López-Ribot J.L. Candida biofilms: an update. Eukaryot Cell 2005, 4:633-638.
29. Ramage G., Martinez J.P., Lopez-Ribot J.L. Candida biofilms on implanted biomaterials: a clinically significant problem. FEMS Yeast Res 2006, 6:979-986.
30. Sardi J.C., Scorzoni L., Bernardi T., Fusco-Almeida A.M., Mendes Giannini M.J. Candida species: current epidemiology, pathogenicity, biofilm formation, natural antifungal products and new therapeutic options. J Med Microbiol 2013, 62:10-24.
31. Seneviratne C.J., Silva W.J., Jin L.J., Samaranayake Y.H., Samaranayake L.P. Architectural analysis, viability assessment and growth kinetics of Candida albicans and Candida glabrata biofilms. Arch Oral Biol 2009, 54:1052-1060.
32. Shafreen R.M., Muthamil S., Pandian S.K. Inhibition of Candida albicans virulence factors by novel levofloxacin derivatives. Appl Microbiol Biotechnol 2014, 98:6775-6785.
33. Srinivasan S., Beema Shafreen R.M., Nithyanand P., Manisankar P., Pandian S.K. Synthesis and in vitro antimicrobial evaluation of novel fluoroquinolone derivatives. Eur J Med Chem 2010, 45:6101-6105.
34. Tsang P.W., Bandara H.M., Fong W.P. Purpurin suppresses Candida albicans biofilm formation and hyphal development. PLoS ONE 2012, 7(11):e50866.
35. Vandenbosch D., Braeckmans K., Nelis H.J., Coenye T. Fungicidal activity of miconazole against Candida spp. biofilms. J Antimicrob Chemother 2010, 65:694-700.
36. Vediyappan G., Dumontet V., Pelissier F., d'Enfert C. Gymnemic acids inhibit hyphal growth and virulence in Candida albicans. PLOS ONE 2013, 8(9):e74189.
37. Yilmaz M., Türk A.O., Tay T., Kivanç M. The antimicrobial activity of extracts of the lichen Cladonia foliacea and its (-)-usnic acid, atranorin, and fumarprotocetraric acid constituents. Z Naturforsch C 2004, 59:249-254.
38. Zhang X., Jacob M.R., Rao R.R., Wang Y.H., Agarwal A.K., Newman D.J., et al. Antifungal cyclic peptides from the marine sponge. Res Rep Med Chem 2012, 2:7-14.
39. Zhao T., Liu Y. N-Acetylcysteine inhibit biofilms produced by Pseudomonas aeruginosa. BMC Microbiol 2010, 10:140.